Employees of Sanofi Bangladesh, a French global pharmaceutical company, have demanded a compensation package from the company within 72 hours.
They made the demand at a human chain in front of National Press Club in Dhaka on Sunday.
Addressing the program, Sanofi Bangladesh Employees Welfare Committee President Anower Hossen said: “If our demands are not met within 72 hours, we will go for tougher actions."
He also sought government intervention to ensure that their demands were met.
“If the company does not roll out the compensation package within the deadline, the employees will go on for symbolic hunger strike at the company's headquarters on October 31," he warned.
Sanofi Bangladesh Employees Welfare Committee General Secretary Sanjeeb Kumar Chakraborty said that they had issued a 48-hour ultimatum on October 21 on the same demand but the authorities did not respond.
He said Sanofi should stay in Bangladesh as the company was a profitable one during the last ten years.
“Now where will we go for jobs if Sanofi leaves Bangladesh? We are helpless,” said Sanjeeb Kumar Chakraborty.
The French pharmaceutical company recently announced its decision to leave Bangladesh for strategic reasons, after selling its 54.64% shares.
Sanofi has around 1,000 employees and many local sellers are directly associated with the business in Bangladesh.
Sanofi Bangladesh is a public limited company, with the government owning 45.36% share.
Sanofi has been marketing global brands like Lantus, Apidra, Taxotere, Eloxatin, Clexane, Amaryl, Insuman, Epilim along with other growth-driving brands, including Sefrad, Sefurox, Kuracef, Curazith, Fimoxyl, Flagyl, Profenid, Xerosec and Sandom in Bangladesh, according to the Metropolitan Chamber of Commerce and Industry.
In July last year, GlaxoSmithKline (GSK), another multinational research-based pharmaceutical and healthcare companies, closed its medicine manufacturing unit in Bangladesh after over six decades of operation.